Budgeting for the new therapy remains a huge challenge, but with emerging evidence and pricing dynamics, plan sponsors should revisit older cost-benefit analyses
A weight gain of 35 pounds should trigger immediate reassessment of dietary and activity patterns
Eur J Endocrinol 156: 663671, 2007
In real clinical practice, dermal fillers are usually the go-to treatment of many people for their nasolabial folds
Retatrutide (LY3437943) is a synthetic peptide investigated in preclinical and phase 2 research models as a triple agonist of GLP-1, GIP, and glucagon receptors
This process enhances the stability, DNA binding ability, and pro-apoptotic function of p53 (101, 102)